As shown in Fig. 7, SIRT2 gene expression and protein levels are increased in the cerebral cortex (Fig. 7a, b) but remains unchanged in serum samples (Fig. 7c) from AD patients compared to control group. Here, SIRT2 is linked to Alzheimer disease.